Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 20,826 | 27,602 | 9,775 | 4,152 | 1,602 |
| Gross Profit | 20,826 | 27,602 | 9,775 | 4,152 | 1,602 |
| Operating Expenses | 79,295 | 89,126 | 89,676 | 91,594 | 25,135 |
| Operating Income | -58,469 | -61,524 | -79,901 | -87,442 | -23,533 |
| Other Income | 978 | -4,427 | 1,410 | 1,022 | 356 |
| Pre-tax Income | -57,491 | -65,951 | -78,491 | -86,420 | -23,177 |
| Income Tax | -594 | -1,184 | -7,353 | -1,207 | 63 |
| Net Income Continuous | -56,897 | -64,767 | -71,138 | -85,213 | -23,240 |
| Net Income | $-56,897 | $-64,767 | $-71,138 | $-85,213 | $-23,240 |
| EPS Basic Total Ops | -0.56 | -0.64 | -0.72 | -0.88 | -0.26 |
| EPS Basic Continuous Ops | -0.56 | -0.64 | -0.72 | -0.88 | -0.26 |
| EPS Diluted Total Ops | -0.56 | -0.64 | -0.72 | -0.88 | -0.26 |
| EPS Diluted Continuous Ops | -0.56 | -0.64 | -0.72 | -0.88 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.65 | -0.79 | N/A | N/A |
| EBITDA(a) | $-54,820 | $-57,980 | $-76,661 | $-84,965 | $-22,179 |